The Future of Cardiology with Dr. James Min
Listen now
Description
Today I am speaking with Dr. James Min on the future of Cardiology. We discuss everything from lab tests to asses cardiac risk to AI-powered imaging. CVD is the leading cause of death today, so monitoring your risk is of the utmost importance. About Dr. Min James K. Min, MD, FACC, FESC, MSCCT, is the Founder & CEO of Cleerly, a digital healthcare company creating a new standard of precision heart care. As a board-certified cardiologist with a clinical focus on cardiovascular disease prevention and imaging, Dr. Min seeks to prevent heart attacks using Cleerly's AI-enabled digital care platform to help physicians precisely identify, define and treat heart disease earlier.Dr. Min is a former Professor of Radiology and Medicine at Weill Cornell Medical College and the Director of the Dalio Institute of Cardiovascular Imaging (ICI) at NewYork-Presbyterian. Over the last 17 years, Dr. Min has published over 500 peer-reviewed manuscripts that have been funded, in part, by numerous grants awarded by the National Institutes of Health and the Dalio Foundation. He has also served as Principal Investigator on numerous landmark multicenter clinical trials and registries, along with serving as the director of a state-of-the-art core laboratory for coronary computed tomography for several multicenter clinical trials.Dr. Min received his BA from the University of Chicago, and his medical degree from Temple University Medical School. He completed his internship, residency and cardiovascular medicine fellowship at the University of Chicago Hospitals.  
More Episodes
Today I am sitting down with my friend, Dave Asprey. Dave is the father of Biohacking and has been a friend and mentor for years. We discuss all things longevity and biohacking! About Dave: Dave Asprey is best known as the founder of Bulletproof Coffee and the entire Biohacking movement. As...
Published 06/06/24
Today Dr. Killen and I discuss hormone optimization and hormone replacement therapy (HRT) for women. She explains that HRT can start in perimenopause, around the age of 35-40, and involves replacing hormones like progesterone, testosterone, and estrogen to maintain optimal levels. She emphasizes...
Published 05/30/24